GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (OTCPK:VIMGF) » Definitions » Total Liabilities

VIMGF (Vimian Group AB) Total Liabilities : $432.6 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Vimian Group AB Total Liabilities?

Vimian Group AB's Total Liabilities for the quarter that ended in Sep. 2024 was $432.6 Mil.

Vimian Group AB's quarterly Total Liabilities declined from Mar. 2024 ($501.35 Mil) to Jun. 2024 ($344.12 Mil) but then increased from Jun. 2024 ($344.12 Mil) to Sep. 2024 ($432.62 Mil).

Vimian Group AB's annual Total Liabilities increased from Dec. 2021 ($318.73 Mil) to Dec. 2022 ($468.29 Mil) and increased from Dec. 2022 ($468.29 Mil) to Dec. 2023 ($487.43 Mil).


Vimian Group AB Total Liabilities Historical Data

The historical data trend for Vimian Group AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB Total Liabilities Chart

Vimian Group AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 52.31 210.83 318.73 468.29 487.43

Vimian Group AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 510.46 487.43 501.35 344.12 432.62

Vimian Group AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Vimian Group AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=81.671+(338.398+67.361
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=487.4

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=1061.815-574.385
=487.4

Vimian Group AB's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=103.879+(275.456+53.289
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=432.6

Total Liabilities=Total Assets (Q: Sep. 2024 )-Total Equity (Q: Sep. 2024 )
=1174.295-741.671
=432.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vimian Group AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Vimian Group AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Vimian Group AB Business Description

Traded in Other Exchanges
Address
Riddargatan 19, Stockholm, SWE, SE-11457
Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.